ACTRN12613000777796已完成2 期
An Open Label Extension Study to Assess the Safety and Tolerability of PBT2, and its Effect on Amyloid Deposition in the Brains of Patients with Prodromal or Mild Alzheimer's Disease.
Alterity Therapeutics0 个研究点目标入组 33 人开始时间: 2013年7月11日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 33
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 55 Years 至 o limit（—）
- 性别
- All
入选标准
- •1. Patients who have completed Visit 10 (Week 52) of the PBT2-204 (IMAGINE) clinical trial [ACTRN12611001008910].
排除标准
- •1. Allergy to PBT2 or its excipients (microcrystalline cellulose, pregelatinised starch, colloidal silicon dioxide, povidone K29/32 and sodium stearyl fumurate).
- •2. Have developed any clinically significant uncontrolled medical, ocular or psychiatric illness during PBT2-204.
研究者
相似试验
进行中（未招募）
1 期
A study to evaluate the long-term safety and tolerability of SEP-363856 in subjects with schizophrenia.MedDRA version: 21.1Level: LLTClassification code 10001064Term: Acute schizophreniaSystem Organ Class: 100000004873MedDRA version: 20.0Level: LLTClassification code 10008525Term: Childhood schizophreniaSystem Organ Class: 100000004873SchizophreniaEUCTR2019-000696-16-BGSumitomo Pharma America, Inc. (SMPA)612
进行中（未招募）
1 期
A study to evaluate the long-term safety and tolerability of SEP-363856 in subjects with schizophrenia.SchizophreniaEUCTR2019-000696-16-HRSunovion Pharmaceuticals Inc.612
进行中（未招募）
1 期
A study to evaluate the long-term safety and tolerability of SEP-363856 in subjects with schizophrenia.SchizophreniaEUCTR2019-000696-16-LVSunovion Pharmaceuticals Inc.612
进行中（未招募）
1 期
A 25 month study of a potential new medicine (GSK1605786A) for the treatment of Crohn’s diseaseEUCTR2010-022384-35-GBGlaxoSmithKline Research & Development Ltd398
进行中（未招募）
1 期
A 25 month study of a potential new medicine (GSK1605786A) for the treatment of Crohn’s diseaseSubjects with Crohn’s DiseaseMedDRA version: 19.0Level: PTClassification code 10011401Term: Crohn's diseaseSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2010-022384-35-DKGlaxoSmithKline Research & Development Ltd800